Jerry Gurwitz to Drug Industry
This is a "connection" page, showing publications Jerry Gurwitz has written about Drug Industry.
Connection Strength
1.040
-
Gurwitz JH. Pharmaceutical Marketing at the 2018 American Geriatrics Society Annual Scientific Meeting: The Case of Noctiva and the Need for Increased Vigilance. J Am Geriatr Soc. 2018 11; 66(11):2045-2047.
Score: 0.610
-
Fischer MA, Keough ME, Baril JL, Saccoccio L, Mazor KM, Ladd E, Von Worley A, Gurwitz JH. Prescribers and pharmaceutical representatives: why are we still meeting? J Gen Intern Med. 2009 Jul; 24(7):795-801.
Score: 0.318
-
Mazor KM, Andrade SE, Auger J, Fish L, Gurwitz JH. Communicating safety information to physicians: an examination of dear doctor letters. Pharmacoepidemiol Drug Saf. 2005 Dec; 14(12):869-75.
Score: 0.063
-
Gurwitz JH, Rochon P. Improving the quality of medication use in elderly patients: a not-so-simple prescription. Arch Intern Med. 2002 Aug 12-26; 162(15):1670-2.
Score: 0.050